{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:16:37Z","timestamp":1774278997058,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST-CSRI\/2021\/550"],"award-info":[{"award-number":["DST-CSRI\/2021\/550"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/005021"],"award-info":[{"award-number":["CRG\/2020\/005021"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11064-025-04495-8","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T02:58:57Z","timestamp":1753498737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polycyclitol Derivatives Restore Long- Term Memory Via cdk5\/p25 Activation of Tau Signaling in Experimental Cerebral Malaria"],"prefix":"10.1007","volume":"50","author":[{"given":"Praveen Kumar","family":"Simhadri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Showkat","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailaja","family":"Karri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal A.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goverdhan","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phanithi Prakash","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"4495_CR1","doi-asserted-by":"publisher","first-page":"1090013","DOI":"10.3389\/fcimb.2023.1090013","volume":"13","author":"P Muppidi","year":"2023","unstructured":"Muppidi P, Wright E, Wassmer SC, Gupta H (2023) Diagnosis of cerebral malaria: tools to reduce plasmodium falciparum associated mortality. Front Cell Infect Microbiol 13:1090013","journal-title":"Front Cell Infect Microbiol"},{"key":"4495_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.neurol.2019.07.008","volume":"175","author":"F Bruneel","year":"2019","unstructured":"Bruneel F (2019) Human cerebral malaria: 2019 mini review. Rev Neurol 175:445\u2013450","journal-title":"Rev Neurol"},{"key":"4495_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.lfs.2012.07.006","volume":"91","author":"M Dai","year":"2012","unstructured":"Dai M, Freeman B, Bruno FP, Shikani HJ, Tanowitz HB, Weiss LM, Reznik SE, Stephani RA, Desruisseaux MS (2012) The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an Artemisinin derivative. Life Sci 91:687\u2013692","journal-title":"Life Sci"},{"key":"4495_CR4","doi-asserted-by":"publisher","first-page":"e1005477","DOI":"10.1371\/journal.ppat.1005477","volume":"12","author":"BD Freeman","year":"2016","unstructured":"Freeman BD, Martins YC, Akide-Ndunge OB, Bruno FP, Wang H, Tanowitz HB, Spray DC, Desruisseaux MS (2016) Endothelin-1 mediates brain microvascular dysfunction leading to Long-Term cognitive impairment in a model of experimental cerebral malaria. PLoS Pathog 12:e1005477","journal-title":"PLoS Pathog"},{"key":"4495_CR5","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1172\/JCI87306","volume":"126","author":"J Gallego-Delgado","year":"2016","unstructured":"Gallego-Delgado J, Basu-Roy U, Ty M, Alique M, Fernandez-Arias C, Movila A, Gomes P, Weinstock A, Xu W, Edagha I, Wassmer SC, Walther T, Ruiz-Ortega M, Rodriguez A (2016) Angiotensin receptors and beta-catenin regulate brain endothelial integrity in malaria. J Clin Investig 126:4016\u20134029","journal-title":"J Clin Investig"},{"key":"4495_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1128\/AAC.05571-11","volume":"56","author":"AC Pena","year":"2012","unstructured":"Pena AC, Penacho N, Mancio-Silva L, Neres R, Seixas JD, Fernandes AC, Romao CC, Mota MM, Bernardes GJ, Pamplona A (2012) A novel carbon monoxide-releasing molecule fully protects mice from severe malaria. Antimicrob Agents Chemother 56:1281\u20131290","journal-title":"Antimicrob Agents Chemother"},{"key":"4495_CR7","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1586\/eri.10.90","volume":"8","author":"CC John","year":"2010","unstructured":"John CC, Kutamba E, Mugarura K, Opoka RO (2010) Adjunctive therapy for cerebral malaria and other severe forms of plasmodium falciparum malaria. Expert Rev anti-infective Therapy 8:997\u20131008","journal-title":"Expert Rev anti-infective Therapy"},{"key":"4495_CR8","doi-asserted-by":"publisher","first-page":"e1000963","DOI":"10.1371\/journal.ppat.1000963","volume":"6","author":"PA Reis","year":"2010","unstructured":"Reis PA, Comim CM, Hermani F, Silva B, Barichello T, Portella AC, Gomes FC, Sab IM, Frutuoso VS, Oliveira MF, Bozza PT, Bozza FA, Dal-Pizzol F, Zimmerman GA, Quevedo J, Castro-Faria-Neto HC (2010) Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog 6:e1000963","journal-title":"PLoS Pathog"},{"key":"4495_CR9","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10571-009-9410-6","volume":"29","author":"J Kanungo","year":"2009","unstructured":"Kanungo J, Zheng YL, Amin ND, Pant HC (2009) Targeting Cdk5 activity in neuronal degeneration and regeneration. Cell Mol Neurobiol 29:1073\u20131080","journal-title":"Cell Mol Neurobiol"},{"key":"4495_CR10","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1242\/dev.119.4.1029","volume":"119","author":"LH Tsai","year":"1993","unstructured":"Tsai LH, Takahashi T, Caviness VS Jr., Harlow E (1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119:1029\u20131040","journal-title":"Development"},{"key":"4495_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/35096019","volume":"2","author":"R Dhavan","year":"2001","unstructured":"Dhavan R, Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2:749\u2013759","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4495_CR12","doi-asserted-by":"publisher","first-page":"11156","DOI":"10.1073\/pnas.96.20.11156","volume":"96","author":"P Sharma","year":"1999","unstructured":"Sharma P, Sharma M, Amin ND, Albers RW, Pant HC (1999) Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc Natl Acad Sci USA 96:11156\u201311160","journal-title":"Proc Natl Acad Sci USA"},{"key":"4495_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/45159","volume":"402","author":"GN Patrick","year":"1999","unstructured":"Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615\u2013622","journal-title":"Nature"},{"key":"4495_CR14","doi-asserted-by":"publisher","first-page":"34202","DOI":"10.1074\/jbc.M110.134643","volume":"285","author":"YL Zheng","year":"2010","unstructured":"Zheng YL, Amin ND, Hu YF, Rudrabhatla P, Shukla V, Kanungo J, Kesavapany S, Grant P, Albers W, Pant HC (2010) A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and Tau hyperphosphorylation. J Biol Chem 285:34202\u201334212","journal-title":"J Biol Chem"},{"key":"4495_CR15","doi-asserted-by":"publisher","first-page":"120986","DOI":"10.1016\/j.lfs.2022.120986","volume":"308","author":"S Maitra","year":"2022","unstructured":"Maitra S, Vincent B (2022) Cdk5-p25 as a key element linking amyloid and Tau pathologies in alzheimer\u2019s disease: mechanisms and possible therapeutic interventions. Life Sci 308:120986","journal-title":"Life Sci"},{"key":"4495_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","volume":"32","author":"JR Sundaram","year":"2012","unstructured":"Sundaram JR, Chan ES, Poore CP, Pareek TK, Cheong WF, Shui G, Tang N, Low CM, Wenk MR, Kesavapany S (2012) Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J Neuroscience: Official J Soc Neurosci 32:1020\u20131034","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"key":"4495_CR17","doi-asserted-by":"publisher","first-page":"e12050","DOI":"10.1002\/trc2.12050","volume":"6","author":"J Cummings","year":"2020","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K (2020) Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement (N Y) 6:e12050","journal-title":"Alzheimers Dement (N Y)"},{"key":"4495_CR18","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.1021\/acs.jmedchem.9b00937","volume":"62","author":"R Malek","year":"2019","unstructured":"Malek R, Arribas RL, Palomino-Antolin A, Totoson P, Demougeot C, Kobrlova T, Soukup O, Iriepa I, Moraleda I, Diez-Iriepa D, Godyn J, Panek D, Malawska B, Gluch-Lutwin M, Mordyl B, Siwek A, Chabchoub F, Marco-Contelles J, Kiec-Kononowicz K, Egea J, de Rios L, Ismaili C L (2019) New dual small molecules for alzheimer\u2019s disease therapy combining Histamine H(3) receptor (H3R) antagonism and calcium channels Blockade with additional cholinesterase Inhibition. J Med Chem 62:11416\u201311422","journal-title":"J Med Chem"},{"key":"4495_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neuropharm.2010.01.016","volume":"59","author":"B Bulic","year":"2010","unstructured":"Bulic B, Pickhardt M, Mandelkow EM, Mandelkow E (2010) Tau protein and Tau aggregation inhibitors. Neuropharmacology 59:276\u2013289","journal-title":"Neuropharmacology"},{"key":"4495_CR20","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1038\/s41467-022-32951-4","volume":"13","author":"PM Seidler","year":"2022","unstructured":"Seidler PM, Murray KA, Boyer DR, Ge P, Sawaya MR, Hu CJ, Cheng X, Abskharon R, Pan H, DeTure MA, Williams CK, Dickson DW, Vinters HV, Eisenberg DS (2022) Structure-based discovery of small molecules that disaggregate alzheimer\u2019s disease tissue derived Tau fibrils in vitro. Nat Commun 13:5451","journal-title":"Nat Commun"},{"key":"4495_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/joim.12959","volume":"286","author":"R Loera-Valencia","year":"2019","unstructured":"Loera-Valencia R, Cedazo-Minguez A, Kenigsberg PA, Page G, Duarte AI, Giusti P, Zusso M, Robert P, Frisoni GB, Cattaneo A, Zille M, Boltze J, Cartier N, Buee L, Johansson G, Winblad B (2019) Current and emerging avenues for alzheimer\u2019s disease drug targets. J Intern Med 286:398\u2013437","journal-title":"J Intern Med"},{"key":"4495_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-161017","volume":"59","author":"M Okuda","year":"2017","unstructured":"Okuda M, Fujita Y, Hijikuro I, Wada M, Uemura T, Kobayashi Y, Waku T, Tanaka N, Nishimoto T, Izumi Y, Kume T, Akaike A, Takahashi T, Sugimoto H (2017) PE859, A novel Curcumin derivative, inhibits Amyloid-beta and Tau aggregation, and ameliorates cognitive dysfunction in Senescence-Accelerated mouse prone 8. J Alzheimer\u2019s Disease: JAD 59:313\u2013328","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"4495_CR23","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1080\/14756366.2020.1835882","volume":"35","author":"N Szalaj","year":"2020","unstructured":"Szalaj N, Godyn J, Jonczyk J, Pasieka A, Panek D, Wichur T, Wieckowski K, Zareba P, Bajda M, Pislar A, Malawska B, Sabate R, Wieckowska A (2020) Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of alzheimer\u2019s disease. J Enzyme Inhib Med Chem 35:1944\u20131952","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4495_CR24","doi-asserted-by":"crossref","unstructured":"Carroll RW, Wainwright MS, Kim KY, Kidambi T, Gomez ND, Taylor T, Haldar K (2010) A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria. PloS one 5","DOI":"10.1371\/journal.pone.0013124"},{"key":"4495_CR25","doi-asserted-by":"publisher","first-page":"21177","DOI":"10.1038\/s41598-021-00402-7","volume":"11","author":"R d\u2019Isa","year":"2021","unstructured":"d\u2019Isa R, Comi G, Leocani L (2021) Apparatus design and behavioural testing protocol for the evaluation of Spatial working memory in mice through the spontaneous alternation T-maze. Sci Rep 11:21177","journal-title":"Sci Rep"},{"key":"4495_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnana.2016.00038","volume":"10","author":"S Zaqout","year":"2016","unstructured":"Zaqout S, Kaindl AM (2016) Golgi-Cox staining step by step. Front Neuroanat 10:38","journal-title":"Front Neuroanat"},{"key":"4495_CR27","doi-asserted-by":"publisher","first-page":"17005","DOI":"10.1002\/chem.202003367","volume":"26","author":"S Rashid","year":"2020","unstructured":"Rashid S, Bhat BA, Mehta G (2020) Conceptualization and synthesis of the first inosito-Inositol (Decahydroxydecalin, DHD): in Silico binding to beta-Amyloid protein. Chemistry 26:17005\u201317010","journal-title":"Chemistry"},{"key":"4495_CR28","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1128\/AAC.01277-10","volume":"55","author":"L Clemmer","year":"2011","unstructured":"Clemmer L, Martins YC, Zanini GM, Frangos JA, Carvalho LJ (2011) Artemether and Artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain. Antimicrob Agents Chemother 55:1383\u20131390","journal-title":"Antimicrob Agents Chemother"},{"key":"4495_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/brain\/awz371","volume":"143","author":"CD Morrone","year":"2020","unstructured":"Morrone CD, Bazzigaluppi P, Beckett TL, Hill ME, Koletar MM, Stefanovic B, McLaurin J (2020) Regional differences in alzheimer\u2019s disease pathology confound behavioural rescue after amyloid-beta Attenuation. Brain 143:359\u2013373","journal-title":"Brain"},{"key":"4495_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/jnc.15972","volume":"167","author":"OB Akide Ndunge","year":"2023","unstructured":"Akide Ndunge OB, Shikani HJ, Dai M, Freeman BD, Desruisseaux MS (2023) Effects of anti-tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria. J Neurochem 167:441\u2013460","journal-title":"J Neurochem"},{"key":"4495_CR31","doi-asserted-by":"publisher","first-page":"e44117","DOI":"10.1371\/journal.pone.0044117","volume":"7","author":"M Dai","year":"2012","unstructured":"Dai M, Freeman B, Shikani HJ, Bruno FP, Collado JE, Macias R, Reznik SE, Davies P, Spray DC, Tanowitz HB, Weiss LM, Desruisseaux MS (2012) Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment. PLoS ONE 7:e44117","journal-title":"PLoS ONE"},{"key":"4495_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/jnr.21850","volume":"87","author":"NE LaPointe","year":"2009","unstructured":"LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, Binder LI, Brady ST (2009) The amino terminus of Tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J Neurosci Res 87:440\u2013451","journal-title":"J Neurosci Res"},{"key":"4495_CR33","first-page":"20130144","volume":"369","author":"T Kimura","year":"2014","unstructured":"Kimura T, Whitcomb DJ, Jo J, Regan P, Piers T, Heo S, Brown C, Hashikawa T, Murayama M, Seok H, Sotiropoulos I, Kim E, Collingridge GL, Takashima A, Cho K (2014) Microtubule-associated protein Tau is essential for long-term depression in the hippocampus. Philosophical Trans Royal Soc Lond Ser B Biol Sci 369:20130144","journal-title":"Philosophical Trans Royal Soc Lond Ser B Biol Sci"},{"key":"4495_CR34","doi-asserted-by":"publisher","first-page":"tgaa018","DOI":"10.1093\/texcom\/tgaa018","volume":"1","author":"M Regalado-Reyes","year":"2020","unstructured":"Regalado-Reyes M, Benavides-Piccione R, Fernaud-Espinosa I, DeFelipe J, Leon-Espinosa G (2020) Effect of phosphorylated Tau on cortical pyramidal neuron morphology during hibernation. Cereb Cortex Commun 1:tgaa018","journal-title":"Cereb Cortex Commun"},{"key":"4495_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2202-12-79","volume":"12","author":"T Kaul","year":"2011","unstructured":"Kaul T, Credle J, Haggerty T, Oaks AW, Masliah E, Sidhu A (2011) Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of parkinson\u2019s disease. BMC Neurosci 12:79","journal-title":"BMC Neurosci"},{"key":"4495_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-017-1674-1","volume":"133","author":"RJ Hatch","year":"2017","unstructured":"Hatch RJ, Wei Y, Xia D, Gotz J (2017) Hyperphosphorylated Tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment. Acta Neuropathol 133:717\u2013730","journal-title":"Acta Neuropathol"},{"key":"4495_CR37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8:663\u2013672","journal-title":"Nat Rev Neurosci"},{"key":"4495_CR38","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.2337\/diabetes.54.12.3343","volume":"54","author":"S Freude","year":"2005","unstructured":"Freude S, Plum L, Schnitker J, Leeser U, Udelhoven M, Krone W, Bruning JC, Schubert M (2005) Peripheral hyperinsulinemia promotes Tau phosphorylation in vivo. Diabetes 54:3343\u20133348","journal-title":"Diabetes"},{"key":"4495_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","volume":"1739","author":"K Iqbal","year":"2005","unstructured":"Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in alzheimer disease and other tauopathies. Biochim Biophys Acta 1739:198\u2013210","journal-title":"Biochim Biophys Acta"},{"key":"4495_CR40","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1210\/en.2009-0695","volume":"150","author":"B Kim","year":"2009","unstructured":"Kim B, Backus C, Oh S, Hayes JM, Feldman EL (2009) Increased Tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150:5294\u20135301","journal-title":"Endocrinology"},{"key":"4495_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1749-6632.1996.tb34407.x","volume":"777","author":"EM Mandelkow","year":"1996","unstructured":"Mandelkow EM, Schweers O, Drewes G, Biernat J, Gustke N, Trinczek B, Mandelkow E (1996) Structure, microtubule interactions, and phosphorylation of Tau protein. Ann N Y Acad Sci 777:96\u2013106","journal-title":"Ann N Y Acad Sci"},{"key":"4495_CR42","doi-asserted-by":"publisher","first-page":"e2138515","DOI":"10.1001\/jamanetworkopen.2021.38515","volume":"4","author":"D Datta","year":"2021","unstructured":"Datta D, Bangirana P, Opoka RO, Conroy AL, Co K, Bond C, Zhao Y, Kawata K, Saykin AJ, John CC (2021) Association of plasma Tau with mortality and Long-term neurocognitive impairment in survivors of pediatric cerebral malaria and severe malarial Anemia. JAMA Netw Open 4:e2138515","journal-title":"JAMA Netw Open"},{"key":"4495_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jns.2007.03.005","volume":"258","author":"IM Medana","year":"2007","unstructured":"Medana IM, Idro R, Newton CR (2007) Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria. J Neurol Sci 258:93\u201398","journal-title":"J Neurol Sci"},{"key":"4495_CR44","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s12035-021-02598-1","volume":"59","author":"SP Kumar","year":"2022","unstructured":"Kumar SP, Babu PP (2022) NADPH oxidase: a possible therapeutic target for cognitive impairment in experimental cerebral malaria. Mol Neurobiol 59:800\u2013820","journal-title":"Mol Neurobiol"},{"key":"4495_CR45","doi-asserted-by":"publisher","first-page":"44795","DOI":"10.1074\/jbc.M408127200","volume":"279","author":"FM Harris","year":"2004","unstructured":"Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y (2004) Increased Tau phosphorylation in Apolipoprotein E4 Transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem 279:44795\u201344801","journal-title":"J Biol Chem"},{"key":"4495_CR46","doi-asserted-by":"publisher","first-page":"115049","DOI":"10.1016\/j.expneurol.2024.115049","volume":"383","author":"P Merino-Serrais","year":"2025","unstructured":"Merino-Serrais P, Soria JM, Arrabal CA, Ortigado-Lopez A, Esparza MAG, Munoz A, Hernandez F, Avila J, DeFelipe J, Leon-Espinosa G (2025) Protein Tau phosphorylation in the proline rich region and its implication in the progression of alzheimer\u2019s disease. Exp Neurol 383:115049","journal-title":"Exp Neurol"},{"key":"4495_CR47","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1073\/pnas.1203140109","volume":"109","author":"RA Rissman","year":"2012","unstructured":"Rissman RA, Staup MA, Lee AR, Justice NJ, Rice KC, Vale W, Sawchenko PE (2012) Corticotropin-releasing factor receptor-dependent effects of repeated stress on Tau phosphorylation, solubility, and aggregation. Proc Natl Acad Sci USA 109:6277\u20136282","journal-title":"Proc Natl Acad Sci USA"},{"key":"4495_CR48","doi-asserted-by":"publisher","first-page":"111161","DOI":"10.1016\/j.brainresbull.2024.111161","volume":"220","author":"J Micheau","year":"2025","unstructured":"Micheau J, Catheline G, Barse E, Hiba B, Marcilhac A, Allard M, Platt B, Riedel G (2025) PLB2(Tau) mice are impaired in novel and Temporal object recognition and show corresponding traits in brain MRI. Brain Res Bull 220:111161","journal-title":"Brain Res Bull"},{"key":"4495_CR49","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/ejn.14918","volume":"53","author":"J Tulloch","year":"2021","unstructured":"Tulloch J, Netsyk O, Pickett EK, Herrmann AG, Jain P, Stevenson AJ, Oren I, Hardt O, Spires-Jones TL (2021) Maintained memory and long-term potentiation in a mouse model of alzheimer\u2019s disease with both amyloid pathology and human Tau. Eur J Neurosci 53:637\u2013648","journal-title":"Eur J Neurosci"},{"key":"4495_CR50","doi-asserted-by":"publisher","first-page":"951202","DOI":"10.3389\/fncel.2022.951202","volume":"16","author":"C Ao","year":"2022","unstructured":"Ao C, Li C, Chen J, Tan J, Zeng L (2022) The role of Cdk5 in neurological disorders. Front Cell Neurosci 16:951202","journal-title":"Front Cell Neurosci"},{"key":"4495_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/etm.2021.11070","volume":"23","author":"Y Ding","year":"2022","unstructured":"Ding Y, Zhang L, Zhou W, Lu H, Gao X, Li J, Liu J, Niu X, Zheng J (2022) Role of cyclin-dependent kinase 5 in early brain injury following experimental subarachnoid hemorrhage. Experimental Therapeutic Med 23:147","journal-title":"Experimental Therapeutic Med"},{"key":"4495_CR52","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s11064-022-03642-9","volume":"47","author":"M Takahashi","year":"2022","unstructured":"Takahashi M, Takasugi T, Kawakami A, Wei R, Ando K, Ohshima T, Hisanaga SI (2022) Valproic Acid-Induced anxiety and depression behaviors are ameliorated in p39 Cdk5 Activator-Deficient mice. Neurochem Res 47:2773\u20132779","journal-title":"Neurochem Res"},{"key":"4495_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fncel.2018.00138","volume":"12","author":"E Kamiki","year":"2018","unstructured":"Kamiki E, Boehringer R, Polygalov D, Ohshima T, McHugh TJ (2018) Inducible knockout of the Cyclin-Dependent kinase 5 activator p35 alters hippocampal Spatial coding and neuronal excitability. Front Cell Neurosci 12:138","journal-title":"Front Cell Neurosci"},{"key":"4495_CR54","doi-asserted-by":"publisher","first-page":"e1900474","DOI":"10.1002\/biot.201900474","volume":"15","author":"M Peyressatre","year":"2020","unstructured":"Peyressatre M, Laure A, Pellerano M, Boukhaddaoui H, Soussi I, Morris MC (2020) Fluorescent biosensor of CDK5 kinase activity in glioblastoma cell extracts and living cells. Biotechnol J 15:e1900474","journal-title":"Biotechnol J"},{"key":"4495_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/JHD-2012-129000","volume":"1","author":"KH Park","year":"2012","unstructured":"Park KH, Lu G, Fan J, Raymond LA, Leavitt BR (2012) Decreasing levels of the cdk5 activators, p25 and p35, reduces excitotoxicity in striatal neurons. J Huntington\u2019s Disease 1:89\u201396","journal-title":"J Huntington\u2019s Disease"},{"key":"4495_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/jnc.13620","volume":"138","author":"MA Yousuf","year":"2016","unstructured":"Yousuf MA, Tan C, Torres-Altoro MI, Lu FM, Plautz E, Zhang S, Takahashi M, Hernandez A, Kernie SG, Plattner F, Bibb JA (2016) Involvement of aberrant cyclin-dependent kinase 5\/p25 activity in experimental traumatic brain injury. J Neurochem 138:317\u2013327","journal-title":"J Neurochem"},{"key":"4495_CR57","doi-asserted-by":"publisher","first-page":"e2217864120","DOI":"10.1073\/pnas.2217864120","volume":"120","author":"PC Pao","year":"2023","unstructured":"Pao PC, Seo J, Lee A, Kritskiy O, Patnaik D, Penney J, Raju RM, Geigenmuller U, Silva MC, Lucente DE, Gusella JF, Dickerson BC, Loon A, Yu MX, Bula M, Yu M, Haggarty SJ, Tsai LH (2023) A Cdk5-derived peptide inhibits Cdk5\/p25 activity and improves neurodegenerative phenotypes. Proc Natl Acad Sci USA 120:e2217864120","journal-title":"Proc Natl Acad Sci USA"},{"key":"4495_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-1027-y","volume":"15","author":"A Wilkaniec","year":"2018","unstructured":"Wilkaniec A, Gassowska-Dobrowolska M, Strawski M, Adamczyk A, Czapski GA (2018) Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity. J Neuroinflamm 15:1","journal-title":"J Neuroinflamm"},{"key":"4495_CR59","doi-asserted-by":"crossref","unstructured":"He M, Wang X, Liu Z, Cui Q, Chen Y, Geng W, Zhu J, Shen J (2022) CDK5 mediates Proinflammatory effects of microglia through activated DRP1 phosphorylation in rat model of intracerebral hemorrhage. Disease markers 2022:1919064","DOI":"10.1155\/2022\/1919064"},{"key":"4495_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neuroscience.2021.03.034","volume":"463","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang Y, Xu M, Miao Z, Tian Y (2021) Inhibition of the CDK5\/caspase-3 pathway by p5-TAT protects hippocampal neurogenesis and alleviates Radiation-induced cognitive dysfunction. Neuroscience 463:204\u2013215","journal-title":"Neuroscience"},{"key":"4495_CR61","doi-asserted-by":"publisher","first-page":"14506","DOI":"10.1096\/fj.201901292R","volume":"33","author":"W Liu","year":"2019","unstructured":"Liu W, Zhou Y, Liang R, Zhang Y (2019) Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits. FASEB Journal: Official Publication Federation Am Soc Experimental Biology 33:14506\u201314515","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"4495_CR62","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1111\/bph.15907","volume":"179","author":"D Medina-Vera","year":"2022","unstructured":"Medina-Vera D, Navarro JA, Rivera P, Rosell-Valle C, Gutierrez-Adan A, Sanjuan C, Lopez-Gambero AJ, Tovar R, Suarez J, Pavon FJ, Baixeras E, Decara J, de Rodriguez F (2022) d-Pinitol promotes Tau dephosphorylation through a cyclin-dependent kinase 5 regulation mechanism: A new potential approach for Tauopathies? Br J Pharmacol 179:4655\u20134672","journal-title":"Br J Pharmacol"},{"key":"4495_CR63","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0028-3908(83)90239-3","volume":"22","author":"H Wachtel","year":"1983","unstructured":"Wachtel H (1983) Potential antidepressant activity of rolipram and other selective Cyclic adenosine 3\u2019,5\u2019-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22:267\u2013272","journal-title":"Neuropharmacology"},{"key":"4495_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.trsl.2017.11.004","volume":"193","author":"AW Schaler","year":"2018","unstructured":"Schaler AW, Myeku N (2018) Cilostazol, a phosphodiesterase 3 inhibitor, activates proteasome-mediated proteolysis and attenuates tauopathy and cognitive decline. Translational Research: J Lab Clin Med 193:31\u201341","journal-title":"Translational Research: J Lab Clin Med"},{"key":"4495_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/ADR-200166","volume":"4","author":"O Sanders","year":"2020","unstructured":"Sanders O (2020) Sildenafil for the treatment of alzheimer\u2019s disease: A systematic review. J Alzheimer\u2019s Disease Rep 4:91\u2013106","journal-title":"J Alzheimer\u2019s Disease Rep"},{"key":"4495_CR66","doi-asserted-by":"crossref","unstructured":"Cuadrado-Tejedor M, Garcia-Barroso C, Sanchez-Arias JA, Rabal O, Perez-Gonzalez M, Mederos S, Ugarte A, Franco R, Segura V, Perea G, Oyarzabal J, Garcia-Osta A (2017) A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer\u2019s Disease Mice. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 42:524\u2013539","DOI":"10.1038\/npp.2016.163"},{"key":"4495_CR67","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ana.25028","volume":"82","author":"PK Simhadri","year":"2017","unstructured":"Simhadri PK, Malwade R, Vanka R, Nakka VP, Kuppusamy G, Babu PP (2017) Dysregulation of LIMK-1\/cofilin-1 pathway: A possible basis for alteration of neuronal morphology in experimental cerebral malaria. Ann Neurol 82:429\u2013443","journal-title":"Ann Neurol"},{"key":"4495_CR68","doi-asserted-by":"crossref","unstructured":"Li S, Zhao X, Lazarovici P, Zheng W (2019) Artemether Activation of AMPK\/GSK3beta(ser9)\/Nrf2 Signaling Confers Neuroprotection towards beta-Amyloid-Induced Neurotoxicity in 3xTg Alzheimer\u2019s Mouse Model. Oxidative medicine and cellular longevity 2019:1862437","DOI":"10.1155\/2019\/1862437"},{"key":"4495_CR69","doi-asserted-by":"crossref","unstructured":"Li HJ, Wang TZ, Hou C, Liu HY, Zhang Y, Xue ZZ, Cai QC, Chen DM, Gao CW, Yang JL, Cong L, Chen Y, Yao Q, Zhu QS, Cao C (2021) Artemether attenuates Abeta25-35-Induced cognitive impairments by downregulating abeta, BACE1, mTOR and Tau proteins. Clinical laboratory 67","DOI":"10.7754\/Clin.Lab.2021.201212"},{"key":"4495_CR70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"4495_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-015-1507-z","volume":"131","author":"J Lewis","year":"2016","unstructured":"Lewis J, Dickson DW (2016) Propagation of Tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:27\u201348","journal-title":"Acta Neuropathol"},{"key":"4495_CR72","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1128\/AAC.00488-13","volume":"57","author":"P Orjuela-Sanchez","year":"2013","unstructured":"Orjuela-Sanchez P, Ong PK, Zanini GM, Melchior B, Martins YC, Meays D, Frangos JA, Carvalho LJ (2013) Transdermal Glyceryl trinitrate as an effective adjunctive treatment with Artemether for late-stage experimental cerebral malaria. Antimicrob Agents Chemother 57:5462\u20135471","journal-title":"Antimicrob Agents Chemother"},{"key":"4495_CR73","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1086\/595735","volume":"199","author":"NA Beare","year":"2009","unstructured":"Beare NA, Harding SP, Taylor TE, Lewallen S, Molyneux ME (2009) Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis 199:263\u2013271","journal-title":"J Infect Dis"},{"key":"4495_CR74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0022-510X(91)90016-Z","volume":"101","author":"TW Polder","year":"1991","unstructured":"Polder TW, Jerusalem CR, Eling WM (1991) Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria. J Neurol Sci 101:35\u201346","journal-title":"J Neurol Sci"},{"key":"4495_CR75","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/infdis\/jir812","volume":"205","author":"MJ Ponsford","year":"2012","unstructured":"Ponsford MJ, Medana IM, Prapansilp P, Hien TT, Lee SJ, Dondorp AM, Esiri MM, Day NP, White NJ, Turner GD (2012) Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis 205:663\u2013671","journal-title":"J Infect Dis"},{"key":"4495_CR76","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.ajpath.2012.08.010","volume":"181","author":"HJ Shikani","year":"2012","unstructured":"Shikani HJ, Freeman BD, Lisanti MP, Weiss LM, Tanowitz HB, Desruisseaux MS (2012) Cerebral malaria: we have come a long way. Am J Pathol 181:1484\u20131492","journal-title":"Am J Pathol"},{"key":"4495_CR77","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1021\/acs.accounts.0c00344","volume":"53","author":"SG Patra","year":"2020","unstructured":"Patra SG, Mizrahi A, Meyerstein D (2020) The role of carbonate in catalytic oxidations. Acc Chem Res 53:2189\u20132200","journal-title":"Acc Chem Res"},{"key":"4495_CR78","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1039\/D0CS00579G","volume":"49","author":"AM Fleming","year":"2020","unstructured":"Fleming AM, Burrows CJ (2020) On the irrelevancy of hydroxyl radical to DNA damage from oxidative stress and implications for epigenetics. Chem Soc Rev 49:6524\u20136528","journal-title":"Chem Soc Rev"},{"key":"4495_CR79","doi-asserted-by":"publisher","first-page":"106772","DOI":"10.1016\/j.nbd.2024.106772","volume":"204","author":"Z He","year":"2025","unstructured":"He Z, Sun J (2025) The role of the neurovascular unit in vascular cognitive impairment: current evidence and future perspectives. Neurobiol Dis 204:106772","journal-title":"Neurobiol Dis"},{"key":"4495_CR80","doi-asserted-by":"publisher","first-page":"1077302","DOI":"10.3389\/fragi.2022.1077302","volume":"3","author":"S Wang","year":"2022","unstructured":"Wang S, Tang C, Liu Y, Border JJ, Roman RJ, Fan F (2022) Impact of impaired cerebral blood flow autoregulation on cognitive impairment. Front Aging 3:1077302","journal-title":"Front Aging"},{"key":"4495_CR81","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0896-6273(03)00259-9","volume":"38","author":"W Noble","year":"2003","unstructured":"Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, Davies P, Burns M, Veeranna, Nixon R, Dickson D, Matsuoka Y, Ahlijanian M, Lau LF, Duff K (2003) Cdk5 is a key factor in Tau aggregation and tangle formation in vivo. Neuron 38:555\u2013565","journal-title":"Neuron"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04495-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:03:47Z","timestamp":1757307827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04495-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4495"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04495-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6559340\/v1","asserted-by":"object"}]},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"250"}}